NasdaqGS - Nasdaq Real Time Price USD

Lexicon Pharmaceuticals, Inc. (LXRX)

Compare
1.3000 +0.0900 (+7.44%)
At close: November 7 at 4:00 PM EST
1.2900 -0.01 (-0.77%)
After hours: 7:26 PM EST
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-195,837.0000
-161,897.0000
-88,851.0000
-87,017.0000
-142,969.0000
Investing Cash Flow
-109,975.0000
-49,943.0000
-71,078.0000
2,110.0000
380,756.0000
Financing Cash Flow
239,158.0000
187,960.0000
142,209.0000
22,709.0000
-147,636.0000
End Cash Position
35,617.0000
22,465.0000
46,345.0000
64,065.0000
126,263.0000
Interest Paid Supplemental Data
13,255.0000
10,057.0000
2,289.0000
799.0000
17,353.0000
Capital Expenditure
-333.0000
-470.0000
-1,326.0000
-1,221.0000
-87.0000
Issuance of Capital Stock
241,288.0000
138,823.0000
94,205.0000
37,084.0000
69,970.0000
Issuance of Debt
--
49,961.0000
48,868.0000
--
--
Repayment of Debt
--
--
--
-11,700.0000
-216,580.0000
Repurchase of Capital Stock
-1,730.0000
-824.0000
-864.0000
-2,675.0000
-1,026.0000
Free Cash Flow
-196,170.0000
-162,367.0000
-90,177.0000
-88,238.0000
-143,056.0000
12/31/2020 - 4/7/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers